Tocontribute for the growth and development in the field of pharmaceutical andclinical pharmacology research wherein my analytical and educational skillscould be utilized to the maximum.

Currentpost-doc research focus is on design, plan and conduct of observational,interventional, retrospective and prospective clinical research studies in cardiovasculardiseases. Have experience in design, conduct, co-ordination ofmulti-centric randomized controlled clinical trials in the area of cancer (leukemia),HIV/AIDS (cryptococcal meningitis)and pharmacokinetic studies. Experienced in industry in area of BA/BEstudies, development of analytical methods using LC/MS-MS, HPLC etc.

 Experienced in teaching and research indevelopment and evaluation of liposomal (amphotericin B), transdermal drugdelivery systems, preclinical studies, radiolabelling studies for treatment offungal infections. Recently worked on studying the effect of oral delivery ofACE2 and Ang-1-7 on pulmonary hypertension, heart failure etc. Studied role of steroids on P-glycoprotein transport studies bothin-vitro and in-vivo, and immunoassay development for dengue virus infection.

Servedas an important team member in design, conduct, and implementation of the postgraduate diploma in pharmaceutical management and M.Sc.Pharmaceutical Medicinecourses at the University level.  Involvedin teaching and guiding postgraduate students (M.S., Ph.D.), acted as an investigatorin various interdisciplinary research projects in infectious diseases, drugdelivery systems and biomedical engineering. Excellent track record ofpublishing research work (over 20) in noted journals like Lancet InfectiousDiseases, Clin. Pharm. Drug Development, Indian Jr of Cancer etc., excellent editing (01 book), grant writing, management,communication, leadership and co-ordination skills. 

*                                     PUBLICATIONS 

2014

1. Jadhav MP, Kshirsagar NA. Access to antifungal medicines in resource poor countries.  Lancet Infect Dis. 2014;14(5):370-1.

2. Bavry AA, Jadhav MP, Huo T, Limacher MC, Pepine CJ. Early invasive versus selective invasive strategies in women with non-ST-elevation acute coronary syndromes – The Lady Gator pilot study. (submitted to Eur.Heart Journal)

3. Carsten Schmalfuss , Pamela Woodard,  Michael Gitter , Manoj Jadhav, Raye Bellinger, Steven Rose, Anthony Bavry.Incidence of acute kidney injury after intravenous administration of iodixanol for computed tomographic angiography. (submitted to the Int. Jr. of Cardiology)

4. Jadhav MP. High Throughput Screening (HTS) for the identification of novel antiviral scaffolds.  Clinical Pharm in Drug Dev.2014: 3:79–83.

2013

5. Jadhav MP, Jadhav PM. What's ailing India's research funding agencies?  Nature India 2013; doi:10.1038/nindia.2013.176.

6. Jadhav MP, Bachhav S, Kshirsagar NA. Development of Clinical Pharmacology in India- perspective of a young researcher. Clinical Pharm in Drug Dev. 2013:2(3);201-204.(Guest Editorial)

7. Jadhav MP, Tang Y, Hochhaus G. Development and validation of LC-MS/MS method for detection and quantification of flunisolide in tissue culture medium. Analytical Letters.  2013;46(9):1355-1363.

8. Jadhav MP, Jadhav PM, Shinde VM, Kadam PS, Kshirsagar NA. Liposomal amphotericin B for the treatment of cryptococcal meningitis in HIV/AIDS patients in India – a pilot pharmacokinetic study. Clinical Pharm in Drug Dev.2013;2(1):48-52.

9. Ingle PB, Jadhav MP. CAM and Conventional medicine: Hand in hand" J Clin Rheumatol. 2013 Jun;19(4):227.

2012

10. Jadhav PM, Shah R, Jadhav MP. Important advances in Malaria vaccine research. Chron Young Sci 2012; 3; 111-20.

11. Jadhav MP, Yeola C, Zope G, Nabar A. Aliskirin: The first direct renin inhibitor for treatment of hypertension: the path of its development. J Postgrad Med.2012, 58(1),32-38.

12. Jadhav MP, Vishal Shinde, Jijina FF, Nithya Gogtay, Nilima Kshirsagar et. al., A Randomized Comparative trial evaluating the safety and efficacy of   liposomal amphotericin (Fungisome) versus conventional amphotericin B in the empirical treatment of Febrile neutropenia in India” Ind. Jr. Cancer, 2012; 49(1); 107-113

2011

13. Jadhav MP., Ingle PB, Shelke SS. Assessment of use of complementary alternative medicine and its impact on quality of life in the patients attending rheumatology clinic, in a tertiary care center in India. Indian Jr of Med Sci. 2011; 65(2); 27-34.

14. Ingle PB, Jadhav MP. A prospective observational study to assess quality of life and prescription pattern in osteoarthritis patients at tertiary health center in Mumbai” accepted and in press Indian Jr of Med Sci, 2011; 65(2);35-40.

15. Jadhav MP, Nagarsenkar MS, Kshirsagar NA, Gaikwad RV, Samad A. Formulation and evaluation of long circulating liposomal amphotericin B, scinti-kinetic study using Tc ^99m   in healthy BALB/c mice.” Ind. Jr. Pharm Sci., 2011: (73) (1); 57-64. 

2010

16. Nilima Kshirsagar, Jadhav MP. Nanotechnology –Public health perspective.  J. Bionanosci. 2010, 4, 14-21.

17. Jadhav MP, Aabha Bamba, Vishal Shinde, Nithya Gogtay, Nilima Kshirsagar et. al., Liposomal amphotericin B (Fungisome ^TM ) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: A multicentric, randomized controlled trial.  J Postgrad Med.; 2010, 56(2), 71-76.

2009 

18. Bamba Aabha V, Jadhav MP, Prabhu R, Ray S, Gogtay Nithya J, Jijina Farah F, Kshirsagar Nilima A. “Refractory Hypokalemia due to  conventional Amphotericin B in Patients with Leukemia” Indian J Cancer, 2009: 41(1); 76-7.

2007

19.  Jadhav  MP and Milind Parle. A review article entitled “Hair analysis: A novel technique for tracing drugs” Indian J. of Pharm. Educ. & Res., 2007, 41(1), 73-77.

20. Jadhav MP., Mehta S., Kshirsagar N.A. An editorial on “Looking for new drugs to treat   dengue fever” J. of Gen. Med., 2007, Vol.19(1); 53-56.

21. Jadhav MP. Kshirsagar N.A. “Nanoparticles-emerging use in medicine” in Technical Review Series (TRS), an official publication of Maharashtra University of Health Sciences, Nasik, India. 2007; 14, 9-17.

22. Jadhav M. P. Aabha Bamba, Kshirsagar N.A. “Invest in Health – Build a Safe Future” in Technical Review Series (TRS) , an official publication of Maharashtra University of Health Sciences, Nashik, India. 2007;17; 1-6.

23. Manoj Jadhav, Aabha Bamba, Nithya Gogtay, Nilima Kshirsagar. “Avian Influenza A (H5N1) infections in Humans” in Technical Review Series, an official publication of Maharashtra University of Health Sciences, Nashik, India. 2007; 20;1-9.

24. Manoj Jadhav, Aabha Bamba, Nithya Gogtay, Nilima Kshirsagar  “Severe Acute Respiratory Syndrome (SARS)” published in the special section on infectious diseases in Technical Review Series (TRS) an official publication of Maharashtra University of Health Sciences, Nashik, India. 2007;20; 21-28.

        ABSTRACTS 

1. Chetan B. Yeola, Gaurav Zope, Pravita Yadav, Sachin Upasani, Sagar Thakkar, Manoj Jadhav, Ashish Nabar. Evaluation of authenticity and rationality of promotional pharmaceutical drug literatures. accepted for the poster presentation for the 40 ^th Annual conference of American College of Clinical Pharmacology held at Chicago between 11-13 September 2011, USA.

2. Jadhav MP, Nagarsenkar MS, Kshirsagar NA, Gaikwad RV. “Formulation and evaluation of long circulating liposomes for amphotericin B, tracer kinetic study using Tc ^99m   in healthy BALB/c mice.” Accepted and presented for the 8^th International symposium of Contorlled Release Society –Indian Chapter, at Mumbai, 26-27 Feb.2009.  

3. Jadhav MP, Aabha Bamba, Vishal Shinde, Jijina FF, Nithya Gogtay, Nilima Kshirsagar et. al., “Liposomal Amphotericin B (Fungisome) ^TM for the empirical treatment of systemic fungal infections febrile neutropenia in India - multicentric, randomized controlled clinical trial in leukemia (ALL, AML) patients- an interim analysis of a prospective study, accepted and presented as oral presentation for the -2^nd Annual conference of South Asian chapter of American College of Clinical Pharmacology held at, Mumbai, India, between 4-5 October 2008.

4. Jadhav MP, Aabha Bamba, Vishal Shinde, Nithya Gogtay, Nilima Kshirsagar et. al., “Liposomal Amphotericin B (Fungisome) ^TM for the treatment of systemic fungal infections (cryptococcal meningitis) in India - multicentric, randomized controlled clinical trial in HIV/AIDS patients– interim analysis of a prospective study. (ISRTCN 52812742)” accepted for the poster presentation for the 36 ^th Annual conference of American College of Clinical Pharmacology held at San Francisco, CA, USA, between 8-11 September 2007.Abstract Published in Journal of Clinical Pharmacology 2007, 42, 1183-1211.

5. S. Agrawal,  Jadhav MP, “In-vitro-in vivo transdermal permeation of carvedilol from chitosan based matrix-type transdermal patches” was accepted for poster presentation in National Biotechnology Conference, organized by American Association of Pharmaceutical Scientists (AAPS), June 18-21 2006, at Boston, MA.